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Continuous biomanufacturing provides many advantages for the production of therapeutic proteins through 
process integration, automation and intensification. Sanofi is currently developing robust cell culture processes 
using ATF perfusion technology to achieve improved volumetric productivity with consistent product quality. This 
presentation is a case study on how we applied intensified process technology on product commercialization.  
Using QbD approach, we successfully implemented an intensified perfusion process coupled with continuous 
capturing on a commercial product life cycle management. For the 2nd generation process, entire production and 
capturing stage is fully integrated and automated. The new perfusion process comprises of high cell density and 
achieves significant increase in volumetric productivity, which allows a substantial footprint reduction and 
increases flexibility in a new facility. More importantly, product quality was remarkably comparable with the 1st 
generation process. Dramatic improvement in process robustness and consistency were demonstrated as well. 
Facilitated by computational fluid dynamics (CFD) simulation, we successfully scaled up to commercial scale. In 
support of technology transfer and manufacturing, process control strategy was drafted based on the results of 
bioreactor characterization using univariate and multivariate studies. 
 
